Continuous and Intermittent Glucose Monitoring in 2023

被引：1
作者：
Dovc, Klemen [1 ,2 ]
Bode, Bruce W. [3 ,4 ]
Battelino, Tadej [1 ,2 ]
机构：
[1] Univ Med Ctr Ljubljana, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[3] Atlanta Diabet Associates, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷
关键词：
DIABETIC-KETOACIDOSIS; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; YOUNG-ADULTS; CHILDREN; ADOLESCENTS; MULTICENTER; TECHNOLOGY; MANAGEMENT; EXERCISE;
D O I：
10.1089/dia.2024.2502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S14 / S31
页数：18
相关论文
共 52 条
  • [11] The Association of Time in Range and Diabetic Complications: The Evidence Is Strong
    Beck, Roy W.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (06) : 375 - 377
  • [12] Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
    Beck, Roy W.
    Bergenstal, Richard M.
    Riddlesworth, Tonya D.
    Kollman, Craig
    Li, Zhaomian
    Brown, Adam S.
    Close, Kelly L.
    [J]. DIABETES CARE, 2019, 42 (03) : 400 - 405
  • [13] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
    Beck, Roy W.
    Riddlesworth, Tonya
    Ruedy, Katrina
    Ahmann, Andrew
    Bergenstal, Richard
    Haller, Stacie
    Kollman, Craig
    Kruger, Davida
    McGill, Janet B.
    Polonsky, William
    Toschi, Elena
    Wolpert, Howard
    Price, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 371 - 378
  • [14] Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE
    Bergenstal, Richard M. M.
    Hachmann-Nielsen, Elise
    Kvist, Kajsa
    Peters, Anne L. L.
    Tarp, Jens Magelund
    Buse, John B. B.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (06) : 378 - 383
  • [15] Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial
    Bolinder, Jan
    Antuna, Ramiro
    Geelhoed-Duijvestijn, Petronella
    Kroeger, Jens
    Weitgasser, Raimund
    [J]. LANCET, 2016, 388 (10057) : 2254 - 2263
  • [16] Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial
    Boucher, Sara E.
    Gray, Andrew R.
    Wiltshire, Esko J.
    de Bock, Martin I.
    Galland, Barbara C.
    Tomlinson, Paul A.
    Rayns, Jenny A.
    MacKenzie, Karen E.
    Chan, Huan
    Rose, Shelley
    Wheeler, Benjamin J.
    [J]. DIABETES CARE, 2020, 43 (10) : 2388 - 2395
  • [17] Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
    Cardona-Hernandez, Roque
    Schwandt, Anke
    Alkandari, Hessa
    Bratke, Heiko
    Chobot, Agata
    Coles, Nicole
    Corathers, Sarah
    Goksen, Damla
    Goss, Peter
    Imane, Zineb
    Nagl, Katrin
    O'Riordan, Stephen M. P.
    Jefferies, Craig
    [J]. DIABETES CARE, 2021, 44 (05) : 1176 - 1184
  • [18] Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study
    Charleer, Sara
    De Block, Christophe
    Van Huffel, Liesbeth
    Broos, Ben
    Fieuws, Steffen
    Nobels, Frank
    Mathieu, Chantal
    Gillard, Pieter
    [J]. DIABETES CARE, 2020, 43 (02) : 389 - 397
  • [19] Continuous and Intermittent Glucose Monitoring in 2022
    Dovc, Klemen
    Bode, Bruce W.
    Battelino, Tadej
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : S15 - S29
  • [20] Eeg-Olofsson K., 2023, Diabetes Vasc Dis Res, V20
123456